{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:32:21Z","timestamp":1785393141766,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejogrb.2024.06.014","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:07:51Z","timestamp":1718208471000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Advancing women\u2019s health: The imperative for public health screening of uterine fibroids for personalized care"],"prefix":"10.1016","volume":"299","author":[{"given":"Danya Lakshmi","family":"Chandrakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh","family":"Aref-Adib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funlayo","family":"Odejinmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0005","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstetr Gynaecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of uterine fibroids \u2013 from menarche to menopause","volume":"59","author":"Wise","year":"2016","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1289\/ehp.1103620","article-title":"Early-life exposures and early-onset uterine leiomyomata in black women in the sister study","volume":"120","author":"D\u2019Aloisio","year":"2012","journal-title":"Environ Health Perspect"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.29309\/TPMJ\/2021.28.01.4359","article-title":"Fibroid uterus: clinical presentation and surgical management in A Tertiary Care Hospital","volume":"28","author":"Bano","year":"2021","journal-title":"Professional Med J"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/1471-0528.16928","article-title":"Appraisal of national and international uterine fibroid management guidelines: a systematic review","volume":"129","author":"Amoah","year":"2022","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0035","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2021.02.040","article-title":"Vitamin D deficiency and uterine fibroids: an opportunity for treatment or prevention?","volume":"115","author":"Islam","year":"2021","journal-title":"Female Sterility"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0040","first-page":"287","article-title":"Burden of uterine fibroids: an African perspective, a call for action and opportunity for intervention","volume":"2","author":"Igboeli","year":"2019","journal-title":"Curr Opin Gynecol Obstetr"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.06.014_b0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1089\/jwh.2015.5531","article-title":"An altered perception of normal: understanding causes for treatment delay in women with symptomatic uterine fibroids","volume":"25","author":"Ghant","year":"2016","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0050","unstructured":"Department of Health and Social Care. Women\u2019s Health Strategy for England. 2022."},{"issue":"21","key":"10.1016\/j.ejogrb.2024.06.014_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115972","article-title":"Evidence-based approach for secondary prevention of uterine fibroids (The ESCAPE approach)","volume":"24","author":"Vafaei","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.014_b0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2018.07.032","article-title":"Impact of uterine fibroids on quality of life: a national cross-sectional survey","volume":"229","author":"Herv\u00e9","year":"2018","journal-title":"Eur Obstetr Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynecol Obstet"},{"issue":"8","key":"10.1016\/j.ejogrb.2024.06.014_b0075","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/humrep\/deh309","article-title":"Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women\u2019s Health Study","volume":"19","author":"Wise","year":"2004","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00001648-199809000-00007","article-title":"Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking","volume":"9","author":"Marshall","year":"1998","journal-title":"Epidemiology"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0085","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000002971","article-title":"Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019: a worldwide database study","author":"Dai","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0090","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/aje\/kwr351","article-title":"Hair relaxer use and risk of uterine leiomyomata in African-American women","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.06.014_b0095","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/aje\/kwi072","article-title":"A prospective study of hypertension and risk of uterine leiomyomata","volume":"161","author":"Boynton-Jarrett","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.06.014_b0100","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG. Int J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/0029-7844(95)00252-M","article-title":"Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States","volume":"86","author":"Velebil","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.014_b0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/EDE.0b013e3181567e92","article-title":"Perceived racial discrimination and risk of uterine leiomyomata","volume":"18","author":"Wise","year":"2007","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.014_b0115","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.fertnstert.2008.08.074","article-title":"Risk factors for surgically-removed fibroids in a large cohort of teachers","volume":"92","author":"Templeman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/01443610400024583","article-title":"Age-related prevalence of sonographically confirmed uterine myomas","volume":"25","author":"Lurie","year":"2005","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2188\/jea.12.249","article-title":"Familial aggregation of uterine Myomas in Japanese women","volume":"12","author":"Sato","year":"2002","journal-title":"J Epidemiol"},{"issue":"R1","key":"10.1016\/j.ejogrb.2024.06.014_b0130","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1093\/hmg\/ddm043","article-title":"Genetic heterogeneity among uterine leiomyomata: insights into malignant progression","volume":"16","author":"Hodge","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","article-title":"Vitamin D and risk of uterine fibroids","volume":"24","author":"Baird","year":"2013","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ijgo.13692","article-title":"Nutraceuticals in fibroid management after ulipristal acetate administration: an observational study on patients\u2019 compliance","volume":"156","author":"Tinelli","year":"2022","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.014_b0145","article-title":"Vitamin D plus epigallocatechin gallate: a novel promising approach for uterine myomas","volume":"24","author":"Porcaro","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0150","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1007\/s43032-023-01289-7","article-title":"The gut microbiota: a novel player in the pathogenesis of uterine fibroids","volume":"30","author":"Vk","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0155","unstructured":"InformedHealth.org. Cologne Germany: Institute for Quality and Efficiency in Health Care (IQWiG) [Online]. 2019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279418\/."},{"key":"10.1016\/j.ejogrb.2024.06.014_b0160","unstructured":"Royal College of Obstetricians and Gynaecologists. Better for Women - Improving the health and wellbeing of girls and women. 2019."},{"issue":"14","key":"10.1016\/j.ejogrb.2024.06.014_b0165","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1576\/toag.6.1.21.26976","article-title":"Principles of screening","volume":"6","author":"Cuckle","year":"2004","journal-title":"Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0175","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1192\/bjo.2023.49","article-title":"Quantifying the psychological and behavioural consequences of a diagnostic label for non-cancer conditions: systematic review","volume":"9","author":"Sims","year":"2023","journal-title":"BJPsych Open"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.014_b0180","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/uog.7482","article-title":"The natural history of fibroids","volume":"35","author":"Mavrelos","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.014_b0190","first-page":"15","article-title":"Presentation and treatment of uterine leiomyoma in adolescence: a systematic review","volume":"15","author":"Moroni","year":"2015","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13669-018-0243-5","article-title":"Natural history of uterine fibroids: a radiological perspective","volume":"7","author":"Ghosh","year":"2017","journal-title":"Curr Obstetr Gynecol Rep"},{"issue":"50","key":"10.1016\/j.ejogrb.2024.06.014_b0200","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283201","article-title":"Age of first diagnosis and incidence rate of uterine fibroids in Ghana. A retrospective cohort study","volume":"18","author":"Edzie","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0210","first-page":"458","article-title":"What is the appropriate diagnostic evaluation of fibroids?","volume":"54","author":"Griffin","year":"2005","journal-title":"J Fam Pract"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int J Women\u2019s Health"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0220","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.9778\/cmajo.20200004","article-title":"Quality of ultrasonography reporting and factors associated with selection of imaging modality for uterine fibroids in Canada: results from a prospective cohort registry","volume":"8","author":"Bougie","year":"2020","journal-title":"CMAJ Open"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.12.037","article-title":"Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care","volume":"200","author":"Levens","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2024.06.014_b0230","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bpobgyn.2015.03.014","article-title":"Hysteroscopy and the treatment of uterine fibroids","volume":"29","author":"Emanuel","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1479-828X.2005.00336.x","article-title":"Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies","volume":"45","author":"Cepni","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jeud.2023.100018","article-title":"Prevention of uterine fibroids: molecular mechanisms and potential clinical application","author":"Ali","year":"2023","journal-title":"J Endometriosis Uterine Disord"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0245","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jmig.2013.11.011","article-title":"Imaging for uterine myomas and adenomyosis","volume":"21","author":"Shwayder","year":"2014","journal-title":"Minimally Invasive Gynaecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.06.014_b0250","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1185\/03007995.2015.1069738","article-title":"Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis","volume":"31","author":"Fuldeore","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejogrb.2021.08.024","article-title":"Each Uterus Counts: A narrative review of health disparities in benign gynaecology and minimal access surgery","volume":"265","author":"Ptacek","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0260","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroids for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0265","first-page":"125","article-title":"Current trends in the evaluation and management of uterine fibroids","volume":"11","author":"Vanderhoff","year":"2022","journal-title":"Reprod Endocrinol Infertility"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.annepidem.2013.03.003","article-title":"Self-reported family history of leiomyoma: not a reliable marker of high risk","volume":"23","author":"Saldana","year":"2013","journal-title":"Ann Epidemiol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/GCO.0000000000000907","article-title":"Oral gonadotrophin-releasing hormone (GnRH) antagonists: the continuing search for the ideal nonsurgical therapy of uterine fibroids with a cautionary tale","volume":"35","author":"Sim-Ifere","year":"2023","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"19","key":"10.1016\/j.ejogrb.2024.06.014_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194389","article-title":"Conservative management of uterine fibroid-related heavy menstrual bleeding and infertility: time for a deeper mechanistic understanding and an individualised approach","volume":"10","author":"Dolmans","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0285","unstructured":"Gliklich RE, Leavy MB, Velentgas P, Campion DM, Mohr P, Sabharwal R, Whicher D, Myers ER, Nicholson WK. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease. A Report on the Priority-Setting Process, Preliminary Data Analysis, and Research Plan. Rockville, MD: Agency for Healthcare Research and Quality. 2011."},{"issue":"S1","key":"10.1016\/j.ejogrb.2024.06.014_b0290","doi-asserted-by":"crossref","DOI":"10.1089\/pop.2017.0151","article-title":"Women with newly diagnosed uterine fibroids: treatment patterns and cost comparison for select treatment options","volume":"21","author":"Bonafede","year":"2018","journal-title":"Popul Health Manag"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.014_b0295","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","article-title":"The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013","volume":"213","author":"Soliman","year":"2015","journal-title":"Am J Obstetr Gynaecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.06.014_b0300","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0305","unstructured":"NICE. Relugolix\u2013estradiol\u2013norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. 2022."},{"issue":"3","key":"10.1016\/j.ejogrb.2024.06.014_b0310","doi-asserted-by":"crossref","first-page":"e527","DOI":"10.1016\/j.fertnstert.2020.09.016","article-title":"Efficacy and safety of linzagolix (LGX) for the treatment of heavy menstrual bleeding (HMB) due to uterine fibroids (UF): Results from two phase 3 randomized clinical trials","volume":"114","author":"Stewart","year":"2020","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0315","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.fertnstert.2009.02.069","article-title":"Uterine artery embolization for fibroids is associated with an increased risk of miscarriage","volume":"94","author":"Homer","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0320","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/gyn.2023.0064","article-title":"Update on conservative surgery for fibroids: laparoscopic radiofrequency and transcervical fibroid ablation","volume":"40","author":"Shukr","year":"2024","journal-title":"J Gynaecol Surg"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0325","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.13.11446","article-title":"MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis","author":"Kong","year":"2014","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0330","unstructured":"NICE. Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids. 2021."},{"issue":"2","key":"10.1016\/j.ejogrb.2024.06.014_b0335","doi-asserted-by":"crossref","first-page":"695","DOI":"10.21873\/invivo.11826","article-title":"Surgical intervention for uterine fibroids. Our 4-year experience and literature review: is it time to centralise care provision via specialist fibroid centres?","volume":"34","author":"Strong","year":"2020","journal-title":"In Vivo"},{"issue":"252","key":"10.1016\/j.ejogrb.2024.06.014_b0340","article-title":"Cost effectiveness analysis of total laparoscopic hysterectomy versus total abdominal hysterectomy for uterine fibroids in Western China: a societal perspective","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Health Service Res"},{"key":"10.1016\/j.ejogrb.2024.06.014_b0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejogrb.2024.03.045","article-title":"The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon","volume":"297","author":"Giannini","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ejogrb.2024.06.014_b0350","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.3802\/jgo.2016.27.e37","article-title":"Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio","volume":"27","author":"Bogani","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2024.06.014_b0355","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2024.06.014_b0360","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524003026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:56:47Z","timestamp":1759964207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524003026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":72,"alternative-id":["S0301211524003026"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.06.014","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing women\u2019s health: The imperative for public health screening of uterine fibroids for personalized care","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}